Cellphire Therapeutics raises $15m in Series A funding round
Cellphire Therapeutics, a Maryland-based biotech company focused on the long-term stabilization and storage of platelets, has raised $15 million in a Series A funding round. The financing round was led by Simcah Management. Currently, Cellphire Therapeutics is set to take its two products – Thrombosomes and Cryopreserved Platelets (CPP) in two phase 2 clinical trials […]